NCT07274163Recruiting
Ambispective Registry of Patients Affected by Lung Cancer
Source: ClinicalTrials.gov · Last updated 24 Dec 2025
Brief summary (registry, in English)
Lung cancer is one of the most common cancers and the leading cause of cancer-related death. It is often diagnosed late, and there are different types of lung cancer. Today, many patients benefit from targeted therapies and immunotherapy, which have improved survival. This study will create an ambispective clinical registry of all lung cancer patients treated at Policlinico San Matteo. The registry will collect data from 2019 to 2035 to better understand: 10-year overall survival, how the disease progresses over time, how patients respond to treatments and possible side effects, how patient and tumor characteristics influence treatment choices, how different therapies work in real-world practice. All data will be securely collected whithin REDCap platform and used to improve future care and research.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1500 (estimated)
- First submitted
- 27 Nov 2025
- Start date
- 1 Jan 2019
- Primary completion date
- Dec 2035
- Lead sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Diseases
- Lung cancer
- NCT number
- NCT07274163
What you commit to
- Study type: Observational
- Planned participants: 1500
- From 1 Jan 2019 to the primary completion date, Dec 2035
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients who are unable to understand informed consent document.
Who the study is looking for
- Patients ≥ 18 years diagnosed with and/or treated for lung cancer at the department of SC Oncologia 1 Unit of the Fondazione IRCCS Policlinico San Matteo;
- Prospective patients (or their or legal guardians) who have the ability to understand and be willing to sign a written informed consent document;
- Retrospective patients who have signed the institutional document allowing the use of their data for research on their disease.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fondazione IRCCS Policlinico San Matteo Coordinator of this site? Confirm its status | Pavia | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.